pyrazines has been researched along with Liver Cirrhosis in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (30.95) | 18.7374 |
| 1990's | 3 (7.14) | 18.2507 |
| 2000's | 8 (19.05) | 29.6817 |
| 2010's | 17 (40.48) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Z; He, S; Hu, Z; Jiang, K; Lin, C; Su, H; Yuan, G; Zeng, Y; Zhong, F | 1 |
| Lin, J; Wang, SY | 1 |
| Choi, YK; Jang, BK; Jung, GS; Jung, YA; Kim, HS; Kim, JG; Kim, MK; Lee, IK; Park, KG; Seo, HY | 1 |
| Cao, HJ; Hu, HJ; Li, SG; Liu, J; Lv, B; Zhong, JH; Zhou, J; Zhu, L | 1 |
| Lian, N; Lu, C; Lu, Y; Wu, X; Xiong, X; Zhang, F; Zheng, S | 1 |
| Cai, B; Cai, H; Cao, G; Hu, J; Wu, X | 1 |
| Lu, C; Shao, J; Xu, W; Zhang, F; Zheng, S | 1 |
| Bian, M; Chen, A; Chen, X; Hao, M; Jia, Y; Jin, H; Lian, N; Lu, C; Shao, J; Wu, L; Yao, S; Zhang, C; Zhang, F; Zheng, S | 1 |
| Lin, Q; Qian, L; Shao, J; Zhang, C; Zhang, F; Zhang, Z; Zhao, S; Zheng, S | 1 |
| Chen, A; Hao, M; Jin, H; Lian, N; Shao, J; Wu, L; Yao, Z; Zhang, F; Zheng, S | 1 |
| Chen, A; Shao, J; Yao, Z; Zhang, F; Zhang, Z; Zhao, S; Zheng, S | 1 |
| Kang, KW | 1 |
| Brooks, JS; Brooks, SC; Kim, SG; Lee, MG; Lee, WH | 1 |
| Li, S; Lu, B; Si, S; Yu, L; Zeng, Y | 1 |
| Cho, SH; Choi, JY; Choi, YH; Chon, CY; Han, JY; Jang, JJ; Jang, JW; Kim, SG; Kim, YM; Lee, DH; Lee, MG; Lee, YS; Um, SH; Yu, ES | 1 |
| Cho, SH; Choi, JY; Chon, CY; Han, JY; Jang, JJ; Jang, JW; Kim, SG; Kim, YM; Lee, DH; Lee, YS; Um, SH; Yu, E | 1 |
| Isogawa, A; Iwamoto, M; Koike, K; Ohki, T; Ohsugi, M; Omata, M; Tagawa, K; Toda, N; Yoshida, H | 1 |
| Fujisawa, K; Hirose, Y; Matsumoto, T; Murata, Y; Saeki, I; Sakaida, I; Takami, T; Terai, S; Yamamoto, N; Yamasaki, T | 1 |
| Chen, L; Kong, D; Lu, Y; Ni, C; Zhang, F; Zhang, X; Zheng, S; Zhu, X | 1 |
| Chen, L; Kong, DS; Lei, N; Lu, Y; Zhang, F; Zhang, XP; Zhang, ZL; Zheng, SZ; Zhu, XJ | 1 |
| Kang, KW; Kim, CW; Kim, SG; Kim, YG | 1 |
| Anan, A; Baskin-Bey, ES; Bronk, SF; Gores, GJ; Shah, VH; Werneburg, NW | 1 |
| Bae, SK; Kim, JW; Kim, SG; Kim, T; Lee, I; Lee, MG; Lee, SJ | 1 |
| Albrecht, JH; Anan, A; Baskin-Bey, ES; Bronk, SF; Gores, GJ; Isomoto, H; Mott, JL | 1 |
| Cho, IJ; Kim, SG; Kim, SH | 1 |
| Berlind, S; Lundvall, O | 1 |
| Sato, N; Uehara, M | 1 |
| Ha, JR; Kang, KW; Kim, CW; Kim, ND; Kim, SG | 1 |
| Salvatore, C; Schena, FP; Vox, E | 1 |
| Juhos, E; Radó, JP; Sawinsky, I | 1 |
| Juhos, E; Radó, JP | 1 |
| Bianchi Porre, G; Lazzaroni, M; Petrillo, M | 1 |
| Fu, QL | 1 |
| Alberti, KG; Farrer, M; Fulcher, GR; Johnson, AJ; Record, CO | 1 |
| Gilly, R; Herne, N; Le Gall, F; Michaud, J; Roux, M | 1 |
| Bianchi Porro, G; Petrillo, M | 1 |
| Bancons, J; Dubarry, JJ; Quinton, A | 1 |
| Koshikawa, S; Sasaoka, T | 1 |
| Grayer, D; Iber, F | 1 |
| Sanjo, T | 1 |
| Reynolds, TB; Yamada, S | 1 |
| Bardi, A; Generini, G; Merino, I; Plaza de los Reyes, M; Rendic, Y | 1 |
1 review(s) available for pyrazines and Liver Cirrhosis
| Article | Year |
|---|---|
Therapeutic potential of dithiolethiones for hepatic diseases.
Topics: Animals; CCAAT-Enhancer-Binding Protein-beta; Fatty Liver; Glutathione Transferase; Humans; Inactivation, Metabolic; Insulin Resistance; Liver; Liver Cirrhosis; Liver Diseases; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Protein Kinases; Pyrazines; Receptors, Aryl Hydrocarbon; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Thiones; Thiophenes; TOR Serine-Threonine Kinases | 2009 |
6 trial(s) available for pyrazines and Liver Cirrhosis
| Article | Year |
|---|---|
Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1.
Topics: Administration, Oral; Adult; Antiviral Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Thiones; Thiophenes; Transforming Growth Factor beta1 | 2010 |
Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial.
Topics: Adult; Anticarcinogenic Agents; Biomarkers; Biopsy; Collagen; Double-Blind Method; Female; Hepatitis B; Hepatitis C; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Thiones; Thiophenes; Transforming Growth Factor beta1 | 2011 |
[Effects of a potassium-sparing diuretic in cardiac edema and ascitic cirrhosis].
Topics: Aged; Amiloride; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Edema; Female; Heart Diseases; Humans; Hydrochlorothiazide; Liver Cirrhosis; Male; Middle Aged; Pyrazines | 1977 |
[Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
Topics: Amiloride; Ascites; Chlorides; Clinical Trials as Topic; Furosemide; Humans; Hydrochlorothiazide; Hypokalemia; Hyponatremia; Liver Cirrhosis; Pyrazines; Water-Electrolyte Balance | 1975 |
Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis.
Topics: 3-Hydroxybutyric Acid; Aged; Blood Glucose; Fatty Acids; Fatty Acids, Nonesterified; Glucose Tolerance Test; Glycerol; Humans; Hydroxybutyrates; Hypolipidemic Agents; Insulin Resistance; Lipolysis; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Reference Values | 1992 |
Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
Topics: Acid-Base Equilibrium; Amidines; Ascites; Autopsy; Carcinoma; Diuretics; Ethacrynic Acid; Humans; Hydrochlorothiazide; Hydrogen-Ion Concentration; Hyperkalemia; Liver Cirrhosis; Liver Neoplasms; Pyrazines; Spironolactone; Triamterene; Water-Electrolyte Balance | 1970 |
35 other study(ies) available for pyrazines and Liver Cirrhosis
| Article | Year |
|---|---|
Tetramethylpyrazine ameliorates hepatic fibrosis through autophagy-mediated inflammation.
Topics: Animals; Autophagy; Carbon Tetrachloride; Cell Line, Tumor; Chromones; Chronic Disease; Fibrinolytic Agents; Hepatic Stellate Cells; Inflammation; Liver Cirrhosis; Male; Microscopy, Fluorescence; Morpholines; Phosphatidylinositol 3-Kinases; Platelet-Derived Growth Factor; Pyrazines; Rats; Rats, Sprague-Dawley; Signal Transduction | 2020 |
Letter: the efficacy of oltipraz in patients with non-alcoholic fatty liver disease has not been confirmed.
Topics: Fatty Liver; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Pyrazines; Thiones; Thiophenes | 2017 |
Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Topics: Animals; Biomarkers; Blotting, Western; Choline Deficiency; Diet; Dipeptidyl-Peptidase IV Inhibitors; Endoplasmic Reticulum Stress; Fatty Liver; Immunoenzyme Techniques; Inflammation; Lipid Peroxidation; Liver Cirrhosis; Male; Methionine; Mice; Mice, Inbred C57BL; NF-kappa B; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sitagliptin Phosphate; Triazoles; Triglycerides | 2014 |
Effects of miR-9 and tetramethylpyrazine on activation of hepatic stellate cells.
Topics: Actins; Collagen Type I; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Janus Kinase 1; Leptin; Ligusticum; Liver Cirrhosis; MicroRNAs; Phosphorylation; Phytotherapy; Plant Extracts; Pyrazines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Transfection; Up-Regulation | 2015 |
Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway.
Topics: Animals; Carrier Proteins; Caspase 1; Cytokines; Hepatocytes; Inflammasomes; Inflammation; Inflammation Mediators; Liver Cirrhosis; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Platelet-Derived Growth Factor; Pyrazines; Rats; Rats, Sprague-Dawley | 2015 |
Tetramethylpyrazine Inhibits Activation of Hepatic Stellate Cells through Hedgehog Signaling Pathways In Vitro.
Topics: Apoptosis; Cell Line; Cell Proliferation; Connective Tissue Growth Factor; Cyclin-Dependent Kinases; Gene Expression Regulation; Genetic Diseases, Inborn; Hedgehog Proteins; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Pyrazines; Signal Transduction | 2015 |
Nrf2 knockdown attenuates the ameliorative effects of ligustrazine on hepatic fibrosis by targeting hepatic stellate cell transdifferentiation.
Topics: Animals; beta Catenin; Carbon Tetrachloride; Cell Line; Cell Transdifferentiation; Gene Knockdown Techniques; Genetic Therapy; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Mice, Inbred ICR; NF-E2-Related Factor 2; Pyrazines | 2016 |
Inhibition of YAP signaling contributes to senescence of hepatic stellate cells induced by tetramethylpyrazine.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Proliferation; Cellular Senescence; Hepatic Stellate Cells; Liver Cirrhosis; Male; Mice; Mice, Inbred ICR; Phosphoproteins; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; YAP-Signaling Proteins | 2017 |
Tetramethylpyrazine attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic angiogenesis in rats.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; bcl-2-Associated X Protein; Becaplermin; Carbon Tetrachloride; Down-Regulation; Endothelial Cells; Hepatocytes; Liver; Liver Cirrhosis; Male; Neovascularization, Pathologic; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-sis; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis.
Topics: Animals; Benzoquinones; Carbon Tetrachloride; Disease Models, Animal; Hedgehog Proteins; Hepatic Stellate Cells; HSP90 Heat-Shock Proteins; Hypoxia-Inducible Factor 1, alpha Subunit; Lactams, Macrocyclic; Liver Cirrhosis; Male; Mice; Mice, Inbred ICR; Mustard Compounds; Neovascularization, Pathologic; Phenylpropionates; Pyrazines; Rats; Rats, Sprague-Dawley; Signal Transduction; Smoothened Receptor | 2017 |
Tetramethylpyrazine attenuates sinusoidal angiogenesis via inhibition of hedgehog signaling in liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Gene Expression Regulation; Hedgehog Proteins; Humans; Liver Cirrhosis; Mice; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase; Primary Cell Culture; Pyrazines; Smoothened Receptor | 2017 |
This month in APR.
Topics: Animals; CCAAT-Enhancer-Binding Protein-beta; Cell Proliferation; Cyclin E; Dose-Response Relationship, Drug; Hepatectomy; Hepatocyte Growth Factor; Humans; Liver; Liver Cirrhosis; Liver Regeneration; Phosphatidylinositol 3-Kinases; Pyrazines; Rats; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Thiones; Thiophenes; Time Factors | 2009 |
Alleviation of CCl4-induced cirrhosis in rats by tetramethylpyrazine is associated with downregulation of leptin and TGF-beta1 pathway.
Topics: Animals; Blotting, Western; Carbon Tetrachloride; Down-Regulation; Fibrinolytic Agents; Histocytochemistry; Leptin; Liver Cirrhosis; Male; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Leptin; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta1 | 2010 |
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.
Topics: Adult; Alanine Transaminase; Blood Glucose; Body Weight; Comorbidity; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Inflammation; Liraglutide; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Odds Ratio; Pioglitazone; Platelet Count; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles | 2012 |
Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Carcinoma, Hepatocellular; Cell Death; Liver Cirrhosis; Liver Neoplasms; Male; Pyrazines; Rats; Rats, Wistar | 2013 |
Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways.
Topics: Antioxidants; Apoptosis; Blotting, Western; Cell Proliferation; Flow Cytometry; Genetic Markers; Hepatic Stellate Cells; Hydrogen Peroxide; Indicators and Reagents; Liver Cirrhosis; MAP Kinase Signaling System; Oxidants; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polymerase Chain Reaction; Pyrazines; Reactive Oxygen Species; Receptor, Platelet-Derived Growth Factor beta; RNA | 2012 |
Tetramethylpyrazine induces G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and caspase-dependent apoptosis through modulating ERK/p53 signaling in hepatic stellate cells in vitro.
Topics: Animals; Apoptosis; Caspases; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; G1 Phase Cell Cycle Checkpoints; Hepatic Stellate Cells; Hepatocytes; Liver Cirrhosis; Male; MAP Kinase Signaling System; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Pyrazines; Rats; Tumor Suppressor Protein p53 | 2013 |
The anti-fibrogenic effect of a pharmaceutical composition of [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB).
Topics: Animals; Drug Combinations; Hydrocarbons, Chlorinated; Liver Cirrhosis; Pharmaceutical Preparations; Pyrazines; Rats; Rats, Sprague-Dawley; Thiones; Thiophenes | 2002 |
Proteasome inhibition induces hepatic stellate cell apoptosis.
Topics: Animals; Apoptosis; Bile Ducts; Boronic Acids; Bortezomib; Cell Line; Humans; Leupeptins; Ligation; Liver; Liver Cirrhosis; Mice; NF-kappa B; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Rats; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor | 2006 |
Pharmacokinetics and therapeutic effects of oltipraz after consecutive or intermittent oral administration in rats with liver cirrhosis induced by dimethylnitrosamine.
Topics: Administration, Oral; Alkylating Agents; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Creatinine; Dimethylnitrosamine; Half-Life; Hematocrit; Liver; Liver Cirrhosis; Male; Organ Size; Pyrazines; Rats; Rats, Wistar; Schistosomicides; Thiones; Thiophenes | 2006 |
Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse.
Topics: Animals; Bile Ducts; Boronic Acids; Bortezomib; Cell Count; Cholestasis; Hepatocytes; Liver Cirrhosis; Macrophage Activation; Macrophages; Mice; NF-kappa B; Protease Inhibitors; Proteasome Inhibitors; Pyrazines | 2006 |
Inhibition of TGFbeta1-mediated PAI-1 induction by oltipraz through selective interruption of Smad 3 activation.
Topics: Active Transport, Cell Nucleus; Animals; Antiviral Agents; Cell Line; Cell Nucleus; Humans; Liver Cirrhosis; Mice; Plasminogen Activator Inhibitor 1; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad Proteins; Thiones; Thiophenes; Transforming Growth Factor beta1 | 2006 |
Clinical trial of a potassium-sparing saluretic pyrazine derivative (MK-870).
Topics: Adult; Aged; Carbon Dioxide; Chlorides; Creatine; Diuretics; Edema; Female; Heart Failure; Humans; Liver Cirrhosis; Male; Middle Aged; Potassium; Pyrazines; Sodium; Uric Acid | 1967 |
Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.
Topics: Alanine Transaminase; Bilirubin; Carcinoma, Hepatocellular; Chronic Disease; Female; Free Radicals; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Luminescent Measurements; Luminol; Male; Middle Aged; Neutrophils; Oxygen; Prothrombin Time; Pyrazines; Serum Albumin | 1994 |
2-(Allylthio)pyrazine, a cancer chemopreventive agent, inhibits liver fibrosis induced by dimethylnitrosamine in rats: role of inhibition of transforming growth factor-beta1 expression.
Topics: Animals; Dimethylnitrosamine; Enzyme Inhibitors; Liver; Liver Cirrhosis; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transaminases; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
Topics: Amiloride; Canrenone; Humans; Kidney Tubules; Liver Cirrhosis; Loop of Henle; Male; Middle Aged; Potassium; Pregnadienes; Pyrazines; Sodium; Spironolactone; Triamterene | 1976 |
Opposite effects of spironolactone and amiloride on potassium excretion in a patient with ascites due to liver cirrhosis.
Topics: Amiloride; Ascites; Drug Interactions; Female; Humans; Liver Cirrhosis; Middle Aged; Potassium; Pyrazines; Spironolactone | 1976 |
[Experimental study on yiqi-huoxue therapy of liver fibrosis].
Topics: Alanine Transaminase; Animals; Astragalus propinquus; Carbon Tetrachloride; Collagen; Drugs, Chinese Herbal; Female; Fibrinolytic Agents; Liver; Liver Cirrhosis; Male; Pyrazines; Rats; Rats, Inbred Strains | 1992 |
[Clinical study of amiloride hydrochloride, a diuretic with low potassium loss].
Topics: Arrhythmias, Cardiac; Blood Urea Nitrogen; Cardiac Complexes, Premature; Diuretics; Drug Synergism; Edema; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Hydrochlorothiazide; Liver Cirrhosis; Potassium; Pyrazines; Sodium | 1970 |
Prevention of diuretic-induced electrolyte disturbances by amiloride in patients with ascites due to cirrhosis of the liver.
Topics: Acidosis; Alkalosis; Amiloride; Ascites; Diuretics; Humans; Hypokalemia; Hyponatremia; Liver Cirrhosis; Pyrazines; Water-Electrolyte Balance | 1973 |
[Treatment of the edemato-ascitic syndrome in cirrhotics, role of amiloride (MK870)].
Topics: Adult; Aged; Amiloride; Ascites; Diuretics; Edema; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrazines | 1972 |
Clinical evaluations of a combined application of amiloride (MK-870) and thiazide.
Topics: Adult; Blood Pressure; Diuretics; Female; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Nephrotic Syndrome; Potassium; Pyrazines; Sodium | 1969 |
Effect of amiloride hydrochloride (MK-870) in patients with cirrhosis.
Topics: Diuretics; Edema; Humans; Hypokalemia; Kidney Failure, Chronic; Liver Cirrhosis; Natriuresis; Potassium; Pyrazines | 1969 |
[New diuretics--amiloride].
Topics: Animals; Chemical Phenomena; Chemistry; Diuretics; Heart Diseases; Humans; Hypertension; Kidney Diseases; Liver Cirrhosis; Pyrazines | 1970 |
[The effects of the drug M.K. 870 on the diuresis, salidiuresis and plasma electrolyte concentration in liver cirrhosis patients with ascites].
Topics: Diuresis; Diuretics; Electrolytes; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Pyrazines | 1967 |